In different grades, our results illustrated high expression of FDX1 as a risk factor for WHO II primary glioma (LGG) (p = 0.018) (Figure 8B), and the result was similar to TCGA-LGG (Figure 3C). The gene discussed is FDX1; the disease is central nervous system cancer.